Qihan Biotech
PrivateLast Round
VC Round
Sep 22, 2023
Total Funding Raised
$100.3M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Qihan Biotech is a biotechnology company that develops off-the-shelf cell therapies and xenogeneic organs using multiplex genome editing technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qihan Biotech Comparables
Compare Qihan Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neukio Biotherapeutics | 85% | |
| Adicet Bio | 78% | |
| Allogene Therapeutics | 77% |
Qihan Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 22, 2023 | ||||
| Series A Extension | Mar 29, 2021 | ||||
| Series A Extension | Sep 23, 2019 | ||||
| Series A | Jul 23, 2018 |
Qihan Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | VC Round, Series A Extension |
| Legend Star | Series A Extension |
| 招银国际金融有限公司 | Series A Extension |
| BC Partners | Series A Extension |
| ARCH Venture Partners | Series A |
| Northern Light Venture Capital | Series A, Series A Extension, VC Round |
| Biomatics Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 369% MoM, reaching 9.8K.
- Jul 24, 2026
Monthly visitors grew 300% MoM, reaching 2.1K.
Qihan Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Qihan Biotech's valuation, stock price, and market status.
Is Qixin Biotechnology a public or private company?
Qixin Biotechnology is a private company.
What is the current stock price of Qixin Biotechnology?
Qixin Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Qixin Biotechnology worth (valuation)?
Valuation information for Qixin Biotechnology is not publicly available.
Can I buy Qixin Biotechnology stock?
Qixin Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Qixin Biotechnology's last funding round?
Qixin Biotechnology's most recent funding round was Series B on September 22, 2023.
Who are the main investors in Qixin Biotechnology?
Key investors in Qixin Biotechnology include Matrix, 招银国际金融有限公司, Sequoia Capital, Zhejiang Financial Holding, Lilly Asia Ventures.
Will Qixin Biotechnology IPO soon?
No public IPO plans have been announced for Qixin Biotechnology.
How can I track Qixin Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Qixin Biotechnology's secondary market activity and sign up for updates.